Abstract
The effect of AT III substitution on survival time was studied inP. vinkei infected mice. One hundred mice were infected, randomly selected and allocated to two groups of 40 animals each on day 13 after infection. One group was placebo treated, the other group received 3 IU AT III daily on days 13 to 19. Comparison of the survival time in the log rank test showed a prolongation of the median survival time (5 versus 9 days,P<0,01). It is concluded that AT III might be beneficial in the treatment of severe malaria cases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blauhut B, Kramer H, Vinnazzer H, Bergmann H (1985) Substitution of antithrombin III in shock and DIC: a randomized study. Thomb Res 39:81–89
Dennis LH, Eichelberg JW, Imman MM, Conrad ME (1967) Depletion of coagulation factors in drug-resistantPlasmodium falciparum malaria. Blood 29:713–721
Eulenberg F von, Menges (1986) Plasmaperese bei schwerer Malaria tropica. DMW 111:1301–1302
Gassner A, Pall H, Kleinberger G, Neumann E, Thaler E, Pichler M, Magometschnigg D, Lenzhofer R, Thaler H (1979) Verlauf und Intensivtherapie bei einem Fall von Malaria tropica. Wiener Klin Wochenschr 91:51–53
Horstmann RD, Dietrich M (1985) Hemostatic alterations in malaria correlate to parasitaemia. Blut 51:329–335
Howard NA, Collins WE (1972) Heparin therapy in simianPlasmodium knowlesi malaria. Lancet II:738–739
Jaroonvesama N (1972) Intravascular coagulation in falciparum malaria. Lancet II:221–223
Katsushima T (1987) Malaria situation in Asia with special reference to the Western Pacific region. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg Abt Orig Reihe A 264:333–336
Looareesuwan S, Warrell DA, White NJ, Chanthavarnich P, Warell MJ, Chantaratherakitti S, Changswek S, Chongmankongcheep L, Kanchanaranya C (1983)Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria. Am J Trop Hyg 32:911–915
Mammen EF, Miyakawa T, Phillips TF, Assarian GS, Brown JM, Murano G (1985) Human antithrombin concentrates and experimental disseminated intravascular coagulation. Semin Thromb Hemost 11(4):373–383
Marwoto AH (1987) Malaria studies in Indonesia. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg Abt Orig Reihe A 264:326–332
Pukrittayakamee S, White NJ, Clemens R, Chittamas S, Karges HE, Desakorn V, Looareesuwan S, Bunnag D (1988) Coagulopathy in acute falciparum malaria. XIIth International Congress for Tropical Medicine and Malaria, Amsterdam, September 18–23
Rosenberg RD (1975) Actions and interactions of antithrombin III and heparin. New Engl J Med 292:146–151
Schunkert H, Gladziwa U (1986) Blutaustauschtranfusion bei zerebraler Malaria. DMW 111:1582
Siebenlist D (1987) Plasma-Separation bei Malaria tropica. Gelbe Hefte 2:93–95
Sonnenberg F von, Löscher Th, Nothdurft HD,Prüfer L (1986) Komplizierte Malaria tropica: spezifische und supportive Therapie bei importierten Erkrankungen. DMW 111:934–938
Straub H (1983) Verbrauchskoagulopathie bei Malaria tropica. Gelbe Hefte 1:23–26
Vogel GE, Clemens R, Gerb K, Komm Ch (1987) Treatment of acute liver failure with antithrombin III concentrate. Biol Clin Hematol 9 [Suppl 1]:129–134
WHO (1987) World malaria situation 1987. World Health Stat Q 40:142–170
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clemens, R., Bock, H.L., Enders, B. et al. Antithrombin III substitution affects survival rate in a murine malaria model. Parasitol Res 76, 36–38 (1989). https://doi.org/10.1007/BF00931069
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00931069